Preferred Name |
bimagrumab |
Synonyms |
BYM338 |
ID |
http://purl.bioontology.org/ontology/MESH/C000596367 |
altLabel |
BYM338 BYM-338 |
cui |
C3899948 C3896893 |
HM |
D061067 |
Inverse of RB |
N15SW1DIV8 |
Mapped to | |
MDA |
20150329 |
MeSH Frequency |
30 |
MMR |
20191031 |
notation |
C000596367 |
prefLabel |
bimagrumab |
SC |
1 |
Scope Statement |
for treatment of sporatic inclusion body myositis; in clinical trials (2014) |
SRC |
Neurology. 2014 Dec 9;83(24):2239-46. |
TERMUI |
T000877565 T000877566 T000965526 |
TH |
FDA SRS (2015) NLM (2015) USAN (19XX) INN (19XX) NLM (2020) |
tui |
T116 T129 T121 |
Delete | Mapping To | Ontology | Source |
---|---|---|---|
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116852 | National Cancer Institute Thesaurus / 美国国家癌症研究所词典 | LOOM |